Spartan Bioscience files for creditor protection, lays off nearly 70% of staff
Ottawa biotech firm says it is restructuring in the wake of a “higher-than-expected level of inconclusive results” from its rapid COVID-19 testing device.
Skip to content
Roger Eacock
‘A game-changer’: How Spartan retooled its patented rapid DNA test to tackle COVID-19
Ottawa biotech firm predicts revenues will top $200 million this year – and only rise from there.
Spartan Bioscience says rapid COVID-19 test has Health Canada’s approval
Ottawa company says it plans to begin shipping the device “immediately” to federal and provincial governments as well as commercial customers.
Spartan Bioscience re-submits rapid COVID-19 test to Health Canada for approval
After facing months of delays, Ottawa biotech firm is hoping its rapid testing device is poised to clear the final hurdle before it can go
‘Amazing technology’: New Spartan CEO says Ottawa firm on verge of market breakthrough
Chief executive Roger Eacock says rapid COVID-19 tests are poised to make local biotech company a force on the ‘international stage.’
Get our email updates
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
By signing up you agree to our Terms of Use and Privacy Policy. You may unsubscribe at any time.
The Latest
Video
OBJ360
Sponsored
Sponsored
Campaign to Create Tomorrow
Learn more about The Ottawa Hospital's $500-million fundraising campaign, the largest in our city’s history, which will transform the future of healthcare in Ottawa.
EXPERT BLOGS
Collecting judgments may not be as easy as you think
Matt Cameron
This is your chance to contribute to the revitalization of the ByWard Market!
ByWard Market District Authority
Giving Guide
Big Brothers Big Sisters of Ottawa
Giving Guide
